Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Feb 2026.
- Largest single sale: $4.2M (7,000 shares) of Northrop Grumman on Jan 5, 2026. Filing
- Last sale before this period: Jun 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Northrop Grumman (NOC) | Chair, CEO and President, Director | Jan 8, 2013 | Aug 21, 2026 |
| Merck & Co. (MRK) | Director | Mar 18, 2020 | Jun 2, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 17, 2026, Northrop Grumman: 10,760 shares vested or acquired by exercising options; 4,857 shares withheld by the company for taxes. 1 filing: 1
- Feb 11, 2026, Northrop Grumman: 34,546 shares vested or acquired by exercising options; 15,371 shares withheld by the company for taxes. 1 filing: 1
- Feb 6, 2026, Northrop Grumman: sold 20,000 shares for $14.2M, no plan disclosed. 1 filing: 1
- Jan 6, 2026, Northrop Grumman: sold 3,000 shares for $1.8M, under a disclosed plan. 1 filing: 1
- Jan 5, 2026, Northrop Grumman: sold 7,000 shares for $4.2M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.